Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

Exosome-associated THSD7A is identified as a key trigger of filopodia formation in cancer cells and neurons, revealing a ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

According to the ‘grow or go’ model, cancer cells can switch between invasive and proliferative states. A zebrafish model of skin cancer shows that the invasive switch is triggered by mechanical ...

Researchers at the University of Chicago have developed a modular cancer immunotherapy that can be switched on, off or reprogramed to attack different cancers. Promising initial testing results, ...

The researchers used lipid nanoparticles (LNPs) to deliver cyclic GMP-AMP (cGAMP) synthase (cGAS) mRNA to cancer cells. This results in production of the endogenous stimulator of interferon genes ...

Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...

New Memorial Sloan Kettering Cancer Center research reveals how dormant metastatic cancer cells protect themselves from the ...